New models for large prospective studies: is there a better way?

Area of Science:

• Epidemiology
• Biomedical Research
• Public Health

Background:

• Large prospective cohort studies are essential for identifying disease causes but demand significant long-term investment.
• Existing models include multisite consortia, combined smaller studies, or single large healthcare providers.
• An alternative centralized model, exemplified by UK Biobank, offers a potentially more efficient approach.

Purpose of the Study:

• To highlight the unique strategies employed by the UK Biobank in conducting a large-scale prospective cohort study.
• To identify critical success factors for large-scale research initiatives.
• To explore the potential applicability of these strategies in the United States.

Main Methods:

• The UK Biobank utilized a centralized recruitment and examination strategy through temporary assessment centers.
• Recruitment involved 503,000 participants between 2007 and 2010.
• Key operational aspects included integrated IT, automated biospecimen processing, and autonomous leadership.

Main Results:

• The UK Biobank successfully completed recruitment and examination within budget and ahead of schedule.
• The study demonstrated the effectiveness of a centralized, process-driven approach to large-scale cohort research.
• Success factors included embedding recruitment within outcome-determination structures and ensuring broad participant consent.

Conclusions:

• Large cohort studies necessitate fundamentally different approaches compared to smaller studies, emphasizing "process" expertise alongside scientific rigor.
• Centralized conduct, comprehensive IT, automated processing, broad consent, and autonomous leadership are critical for success.
• The transportability of these successful UK Biobank strategies to the United States warrants further exploration.